Newspaper publication for the Audited financial results for the quarter and financial year ended on 31st March, 2026.
DSFCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
DCM Shriram Fine Chemicals Ltd has published its audited financial results for Q4 and FY ended March 31, 2026. For the standalone full year, total income declined to Rs 38,771 lakhs from Rs 43,221 lakhs in the previous year, representing approximately 10% revenue decline. The company reported a net loss of Rs 429 lakhs for FY26 compared to a net profit of Rs 1,845 lakhs in FY25. Q4 standalone showed a net loss of Rs 408 lakhs. The significant year-on-year deterioration occurred despite the company completing a major corporate restructuring in December 2025, when the Composite Scheme of Arrangement with DCM Shriram Industries Limited became effective. As part of this demerger, the company received net assets of Rs 15,336 lakhs and issued 8,69,92,185 new equity shares to DCMSR shareholders, which were listed in February 2026. The Board has recommended a final dividend of Rs 0.40 per share (face value Rs 2), subject to shareholder approval.
The company swung to a loss-making position in FY26 with a 10% revenue decline, though the restructuring added assets and a new subsidiary. The new share issuance may dilute earnings per share, while the dividend offer provides some return to shareholders pending approval.